Elizabeth Hurlburt
2021
In 2021, Elizabeth Hurlburt earned a total compensation of $1.1M as Executive Vice President and Head of Clinical Operations at CorMedix.
Compensation breakdown
| Bonus | $37,800 |
|---|---|
| Option Awards | $742,910 |
| Salary | $310,800 |
| Other | $44,818 |
| Total | $1,136,328 |
Hurlburt received $742.9K in option awards, accounting for 65% of the total pay in 2021.
Hurlburt also received $37.8K in bonus, $310.8K in salary and $44.8K in other compensation.
Rankings
In 2021, Elizabeth Hurlburt's compensation ranked 8,346th out of 12,415 executives tracked by ExecPay. In other words, Hurlburt earned more than 32.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,346 out of 12,415 | 33rd |
Division Manufacturing | 3,693 out of 5,505 | 33rd |
Major group Chemicals And Allied Products | 1,641 out of 2,375 | 31st |
Industry group Drugs | 1,460 out of 2,096 | 30th |
Industry Pharmaceutical Preparations | 1,087 out of 1,546 | 30th |
Source: SEC filing on September 13, 2023.
Hurlburt's colleagues
We found six more compensation records of executives who worked with Elizabeth Hurlburt at CorMedix in 2021.
2021
Khoso Baluch
CorMedix
Chief Executive Officer
2021
Thomas Nusbickel
CorMedix
Former Chief Commercial Officer
2021
Phoebe Mounts
CorMedix
General Counsel
2021
Matthew David
CorMedix
Chief Financial Officer
2021
John Armstrong
CorMedix
Former Executive Vice President for Technical Operations
2021
Elizabeth Masson-Hurlburt
CorMedix